Global University Venturing

Matrix Capital Management led the immunology drug developer's series A round, which will support the journey of a type 1 diabetes drug candidate towards the clinic.

Oxford Sciences Innovation returned to reinvest in the smart echocardiogram technology spinout, helping increase its overall funding to nearly $60m.

KAUST agricultural technology spinout Red Sea has added $6m to a pre-series A round featuring the university that now totals $16m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

TU Delft and UMC Utrecht spinout MILabs has been purchased by Rigaku Corporation, which plans to use its medical imaging technology in drug development.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The no-code platform developer, spun out of MIT's Media Lab, will use the cash to boost international growth and accelerate the development of new product features.

Eyevensys has added $12m to its coffers, having previously procured $30m in a series B round backed by Inserm Transfert in early 2020.

The renewable energy battery developer, an MIT spinout, raised funding that will be used to expand its manufacturing capabilities.